NVWM LLC’s West Pharmaceutical WST Stock Holding History

NVWM LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$501	Sell	2 -1	-33%	-$249	﹤0.01%	650
2025 Q4	$825	Buy	3 +1	+50%	+$274	﹤0.01%	593
2025 Q3	$525	Hold	2	–	–	﹤0.01%	591
2025 Q2	$438	Buy	+2	New	+$428	﹤0.01%	607
2025 Q1	–	Sell	-4	Closed	-$1.31K	–	706
2024 Q4	$1.31K	Buy	4 +3	+300%	+$944	﹤0.01%	427
2024 Q3	$300	Buy	+1	New	+$306	﹤0.01%	592
2018 Q4	–	Sell	-400	Closed	-$49K	–	385
2018 Q3	$49K	Hold	400	–	–	0.03%	183
2018 Q2	$40K	Hold	400	–	–	0.03%	186
2018 Q1	$34K	Hold	400	–	–	0.02%	204
2017 Q4	$39K	Buy	+400	New	+$39.2K	0.03%	183

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NVWM LLC's WST Position: Q1 2026 in Review

NVWM LLC reduced its West Pharmaceutical (WST) stake by 33% in Q1 2026, selling an estimated $249 and leaving 2 shares worth $501. The position accounts for ﹤0.01% of the portfolio, ranked #650.

NVWM LLC first reported a position in WST in Q4 2017 and has held it in 10 quarters since. The position peaked at $49K in Q3 2018. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

NVWM LLC held 2 shares of West Pharmaceutical worth $501 as of Q1 2026.
NVWM LLC sold 1 West Pharmaceutical share in Q1 2026, an estimated $249.
West Pharmaceutical made up ﹤0.01% of NVWM LLC's portfolio in Q1 2026, its #650 holding.
NVWM LLC first reported a position in West Pharmaceutical in Q4 2017 and has held it in 10 quarters since.
NVWM LLC's West Pharmaceutical position peaked at $49K in Q3 2018.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.